MedLeanRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Texas-only compounded semaglutide at $149/mo, plus brand options
MedLeanRx scores highest on the strength of its clinical program — drug options and dosing support.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX. It prescribes compounded semaglutide as a weekly injection or daily oral tablet at $149/month and compounded tirzepatide at $269/month, plus a brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/month fee where medication is billed separately. A 5-minute online assessment gets a 24-48 hour physician review, with free shipping and cancel-anytime plans.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to MedLeanRx
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Editorial score · methodology
MedLeanRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Semaglutide Tablets, Brand Wegovy & Zepbound
- Starting price
- $149/mo (Weekly semaglutide vial $149/mo; plans 'start at $149/month for the starting dose' — pricing may vary with medication and dosage)
- What's included
- Medication · Consult · Shipping
- Availability
- 1 states
- FDA status
- No FDA warning letter on record
How we scored MedLeanRx
Each dimension is scored algorithmically from MedLeanRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $149/mo, MedLeanRx runs about 12% below the $169 median for GLP-1 providers, and the first-month promo drops to $163.
Effectiveness25%
8.0/10MedLeanRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
5.4/10MedLeanRx operates in a limited 1-state footprint — check availability first.
Support10%
5.7/10MedLeanRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MedLeanRx review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in 1 state
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with MedLeanRx
We walked MedLeanRx’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Answer a few online health questions in under 5 minutes, no appointment needed.
- 2A licensed physician reviews your health history, BMI, and goals within 24-48 hours.
- 3If approved, medication ships directly to your home in temperature-controlled packaging.
- 4Continue with regular physician follow-ups for progress tracking and dosage adjustments.
- Pricing shown upfront: starting at $149/month; Wegovy pill tier at $99/mo plus medication cost.
- Uses FDA-approved semaglutide (Wegovy) and tirzepatide (Zepbound).
- Intake advertised as under 5 minutes with clinician review in 24-48 hours.
- Medication ships in temperature-controlled packaging.
- No labs or video-visit requirement stated on the page.
GLP-1 medications MedLeanRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly semaglutide vial $149/mo; plans 'start at $149/month for the starting dose' — pricing may vary with medication and dosage
Needle-free daily oral semaglutide tablets, $149/mo
$269/mo standard; intro bundle: 2-month supply at 2 mg weekly for $325 (~$163/mo), Texas clients only, while supplies last
Ready to get started?
Plans and promotions change often — check MedLeanRx's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
- Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
- Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
- LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
- Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips
- 5-minute online assessment with 24-48 hour physician review — 100% online, no clinic visits
Watch-outs
- Texas only — not available in the other 49 states
- Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
- Strict no-refund policy: 'All sales are final' per Terms & Conditions
- Pharmacy partner not publicly named — a transparency gap for a compounding service
- Legal entity name and founding details not published on the site
- Brand-medication total cost not published — $99/mo fee plus the separate cost of medication
Is MedLeanRx worth it? Our verdict
MedLeanRx positions itself around one thing: Texas-only compounded semaglutide at $149/mo, plus brand options. It runs $149/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
What gives MedLeanRx its own flavor: Oral Semaglutide Tablets, Brand Wegovy & Zepbound, and LegitScript Verified.
How much MedLeanRx actually costs
- Compounded semaglutide — $149/month
- Oral semaglutide — $149/month
- Compounded tirzepatide — $163 first month, then $269/month
That puts MedLeanRx below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Found (about $149/month) is one of the closest alternatives to weigh MedLeanRx against.
Medications: what MedLeanRx prescribes
MedLeanRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
MedLeanRx's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who MedLeanRx is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
MedLeanRx is available in 1 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
MedLeanRx earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
MedLeanRx scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with MedLeanRx?
Starting at $149/month. See current pricing and start your free consultation.
MedLeanRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MedLeanRx review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MedLeanRx's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.